- Home
- ARCT vs RAC Comparison
ARCT vs RAC Comparison
Compare ARCT & RAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- RAC
- Stock Information
- Founded
- ARCT 2013
- RAC 2024
- Country
- ARCT United States
- RAC United States
- Employees
- ARCT N/A
- RAC N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- RAC
- Sector
- ARCT Health Care
- RAC
- Exchange
- ARCT Nasdaq
- RAC Nasdaq
- Market Cap
- ARCT 320.8M
- RAC 301.5M
- IPO Year
- ARCT N/A
- RAC 2025
- Fundamental
- Price
- ARCT $20.35
- RAC $10.31
- Analyst Decision
- ARCT Strong Buy
- RAC
- Analyst Count
- ARCT 9
- RAC 0
- Target Price
- ARCT $50.88
- RAC N/A
- AVG Volume (30 Days)
- ARCT 826.4K
- RAC 52.3K
- Earning Date
- ARCT 11-06-2025
- RAC 01-01-0001
- Dividend Yield
- ARCT N/A
- RAC N/A
- EPS Growth
- ARCT N/A
- RAC N/A
- EPS
- ARCT N/A
- RAC N/A
- Revenue
- ARCT $122,122,000.00
- RAC N/A
- Revenue This Year
- ARCT N/A
- RAC N/A
- Revenue Next Year
- ARCT $28.92
- RAC N/A
- P/E Ratio
- ARCT N/A
- RAC N/A
- Revenue Growth
- ARCT N/A
- RAC N/A
- 52 Week Low
- ARCT $8.04
- RAC $9.87
- 52 Week High
- ARCT $24.13
- RAC $10.35
- Technical
- Relative Strength Index (RSI)
- ARCT 54.74
- RAC N/A
- Support Level
- ARCT $20.08
- RAC N/A
- Resistance Level
- ARCT $23.60
- RAC N/A
- Average True Range (ATR)
- ARCT 1.71
- RAC 0.00
- MACD
- ARCT -0.03
- RAC 0.00
- Stochastic Oscillator
- ARCT 43.14
- RAC 0.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About RAC Rithm Acquisition Corp. Class A Ordinary Shares
Rithm Acquisition Corp is a blank check company.